Close Menu

NEW YORK – Natera on Tuesday sued molecular diagnostics and consulting firm Genosity for alleged patent infringement relating to technology from ArcherDx.

In its complaint, filed with the US District Court for the District of Delaware, Natera claimed that several of Genosity's products infringe its US Patent No. 10,732,220, titled "Methods for Simultaneous Amplification of Target Loci."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.